Perspectives on the immunologic microenvironment of astrocytomas

Cancer Management and Research

Volumn 5, Issue 1, 2013, Pages 293-299

  Hewedi, Iman H ^a   Radwan, Nehal A ^a   Shash, Lobna S ^a   Elserry, Tarek H ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Astrocytoma; CD3; CD68; Glioblastoma; Inflammatory cell infiltrate

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CHILD; CONTROLLED STUDY; EGYPT; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PILOCYTIC ASTROCYTOMA; PRESCHOOL CHILD; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT;

EID: 84883622497     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: 10.2147/CMAR.S48942     Document Type: Article

References (19)

1. Auffnger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS. New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med Rep. 2012;4:18.
2. Sonabend AM, Rolle CE, Lesniak MS. The role of regulatory T cells in malignant glioma. Anticancer Res. 2008;28(2B):1143-1150.
3. Yi L, Xiao H, Xu M, et al. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J Neuroimmunol. 2011;232: 75-82.
4. Yang I, Han SJ, Sughrue ME, Tihan T, Parsa AT. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that refect tumor biology. J Neurosurg. 2011;115:505-511.
5. Lohr J, Ratliff T, Huppertz A, et al. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res. 2011;17:4296-4308.
6. Hussain S F, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 2006;8:261-279.
7. Willis SN, Mallozzi SS, Rodig SJ, et al. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J Immunol. 2009;182:3310-3317.
8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumors of the Central Nervous System. Lyon, France: International Agency for Research on Cancer; 2007.
9. Dunn G P, Dunn IF, Curry WT. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun. 2007;7:12.
10. Graeber MB, Scheithauer B W, Kreutzberg GW. Microglia in brain tumors. Glia. 2002;40:252-259.
11. Watters JJ, Schartner JM, Badie B. Microglia function in brain tumors. J Neurosci Res. 2005;81:447-455.
12. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AH, Ballmer-Hofer K, Schwendener RA. Coordinate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer. 2006;95:272-281.
13. Wesolowska A, Kwiatkowska A, Slomnicki L, et al. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion - an inhibition of TGF-beta-dependent effects by SHRNA against human TGF-beta type II receptor. Oncogene. 2008;27:918-930.
14. Hong TM, Teng LJ, Shun CT, Peng MC, Tsai JC. Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol. 2009;93:289-301.
15. Kerber M, Reiss Y, Wickersheim A, et al. Flt-1 signaling in mac-rophages promotes glioma growth in vivo. Cancer Res. 2008;68: 7342-7351.
16. Held-Feindt J, Hattermann K, Müerköster SS, et al. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res. 2010;316:1553-1566.
17. Ueda R, Low KL, Zhu X, et al. Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma. J Transl Med. 2007;5:68.
18. Driggers L, Zhang JG, Newcomb E W, et al. Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper. J Neurooncol. 2010;97:159-169.
19. Zhang JG, Kruse CA, Driggers L, et al. Tumor antigen precursor protein profiles of adult and pediatric brain tumors identifies potential targets for immunotherapy. J Neurooncol. 2008;88:65-76.